Buscar
Mostrando ítems 1-10 de 95
Oxaliplatin-related thrombocytopenia
(Oxford Univ Press, 2012-08-01)
Oxaliplatin is a third generation platinum compound that inhibits DNA synthesis, mainly through intrastrandal cross-links in DNA. Most of the experience with the clinical use of this drug is derived from colorectal cancer ...
Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT(2C) receptor
(Elsevier B.V., 2014-07-15)
Fluoxetine has been shown to be effective in clinical and experimental studies of neuropathic pain. Besides to increase serotonin levels in the synaptic cleft, fluoxetine is able to block the serotonergic 5-HT2C receptor ...
Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition
(Medknow Publications, 2015-04)
AIM OF STUDY: In the present study, we evaluated the effect of ribavirin and metformin on the sensitivity of oxaliplatin and 5-fluorouracil (5-FU) on colon cancer.
MATERIALS AND METHODS: Cell viability of two commercially ...
Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition
(Association of Radiation Oncologists of India, 2015)
Metformin protects from oxaliplatin induced peripheral neuropathy in rats
(Elsevier BV, 2020-08)
Oxaliplatin is a commonly used drug to treat cancer, extending the rate of disease-free survival by 20% in colorectal cancer. However, oxaliplatin induces a disabling form of neuropathy resulting in more than 60% of patients ...
Epithelial-mesenchymal transition and microRNAs in colorectal cancer chemoresistance to FOLFOX
(MDPI, 2021)
The FOLFOX scheme, based on the association of 5-fluorouracil and oxaliplatin, is the most frequently indicated chemotherapy scheme for patients diagnosed with metastatic colorectal cancer. Nevertheless, development of ...
Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer - Case report
(AMER COLL CHEST PHYSICIANS, 2007)
The patient presented here is a 30-year-old woman who underwent anterior resection for the initial treatment of rectal cancer. A postoperative study showed a single liver metastasis. The patient received adjuvant pelvic ...